Announcements Trials

Browse Landscape

Phase

Phase 1 2 Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 17 Other hematologic neoplasm 5 Head & Neck 5 Lymphoid 3 Gynecologic 3 Genitourinary 2 Thoracic 1 Sarcoma 1 Other 1 CNS 1

Conditions

Sarcoma 211 Bone Neoplasms 58 Breast Neoplasms 40 Neoplasms 39 Osteosarcoma 37 Lymphoma 34 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Gastrointestinal Stromal Tumors 31 Dendritic Cell Sarcoma, Interdigitating 31 Hodgkin Disease 29 Lymphoma, Non-Hodgkin 27 Leukemia 27 Burkitt Lymphoma 25 Melanoma 24 Brain Neoplasms 24 Multiple Myeloma 23 Leukemia, Myeloid, Acute 23 Sarcoma, Ewing 22 Recurrence 21 Lymphoma, Mantle-Cell 21 Lymphoma, Large B-Cell, Diffuse 21 Glioblastoma 21 Neuroblastoma 20 Lymphoma, Follicular 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Lymphoma, Large-Cell, Immunoblastic 18 Gliosarcoma 18 Sarcoma, Kaposi 17 Prostatic Neoplasms 17 Pancreatic Neoplasms 17

Interventions

pimonidazole 1 fluoroazomycin arabinoside 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Sarcoma × Clear all

NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting

Hypoxia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡